COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Minnesota patients with a documented clinical need may be eligible for compounded tirzepatide.
Minnesota benefits from Mayo Clinic and strong Twin Cities healthcare infrastructure. Compounding Finder helps Minnesota residents compare licensed pharmacies statewide.
Yes. The Minnesota Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.